Beijing Wantai Biological Pharmacy Enterprise Co Ltd Capital Reinvestment Ratio
Beijing Wantai Biological Pharmacy Enterprise Co Ltd capital reinvestment ratio. Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a Capital Reinvestment Ratio of 0.99x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥127.35 Million) in capital expenditures (CN¥125.45 Million). See cash generation quality of Beijing Wantai Biological Pharmacy Enter to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)
Capital reinvestment ratio of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025. This chart tracks Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Capital Reinvestment Ratio across 13 annual periods. See financial flexibility index of Beijing Wantai Biological Pharmacy Enter to measure the company's free cash flow as a share of total liabilities.
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Capital Reinvestment Ratio by Year (2013–2025)
Beijing Wantai Biological Pharmacy Enterprise Co Ltd capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see 603392 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 8.97x | CN¥89.75 Million | CN¥805.16 Million | ▲ +259.0% |
| 2024 | 2.50x | CN¥355.08 Million | CN¥887.35 Million | ▲ +245.7% |
| 2023 | 0.72x | CN¥1.60 Billion | CN¥1.16 Billion | ▲ +221.3% |
| 2022 | 0.23x | CN¥4.13 Billion | CN¥929.91 Million | ▼ -63.9% |
| 2021 | 0.62x | CN¥1.68 Billion | CN¥1.05 Billion | ▼ -25.3% |
| 2020 | 0.83x | CN¥468.21 Million | CN¥390.44 Million | ▲ +40.4% |
| 2019 | 0.59x | CN¥272.68 Million | CN¥162.00 Million | ▼ -49.7% |
| 2018 | 1.18x | CN¥208.31 Million | CN¥246.06 Million | ▼ -19.1% |
| 2017 | 1.46x | CN¥146.97 Million | CN¥214.65 Million | ▲ +44.0% |
| 2016 | 1.01x | CN¥129.40 Million | CN¥131.26 Million | ▲ +97.7% |
| 2015 | 0.51x | CN¥151.84 Million | CN¥77.92 Million | ▼ -12.2% |
| 2014 | 0.58x | CN¥132.43 Million | CN¥77.43 Million | ▼ -30.3% |
| 2013 | 0.84x | CN¥97.83 Million | CN¥82.12 Million | — |